A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Cell

• Publication date

  2017-06-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccell.2017.04.013PMID 28528867PMCID PMC5502825
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• mTORC1 drives HIF-1  and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3

  2018cited by this paper
• Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.

  2017cited by this paper
• Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling.

  2016cited by this paper
• Emerging role of mTOR in the response to cancer therapeutics.

  2016cited by this paper
• The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

  2016cited by this paper
• The PI3K/AKT Pathway as a Target for Cancer Treatment.

  2016cited by this paper
• pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner

  2016influential reference
• Reverse phase protein arrays in signaling pathways: a data integration perspective

  2015cited by this paper
• Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations.

  2015cited by this paper
• Rapamycin Enhances the Anti-Cancer Effect of Dasatinib by Suppressing Src/PI3K/mTOR Pathway in NSCLC Cells

  2015cited by this paper
• Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

  2015influential reference
• A pan-cancer proteomic perspective on The Cancer Genome Atlas

  2014influential reference
• mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3

  2014cited by this paper
• Discovery and saturation analysis of cancer genes across 21 tumor types

  2014cited by this paper
• PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting

  2014influential reference
• LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures

  2014cited by this paper
• Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.

  2014influential reference
• A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.

  2014cited by this paper
• Mutational landscape and significance across 12 major cancer types

  2013cited by this paper
• Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML.

  2013cited by this paper
• COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA

  2013cited by this paper
• Diverse mechanisms of somatic structural variations in human cancer genomes.

  2013cited by this paper
• Pan-cancer patterns of somatic copy-number alteration

  2013cited by this paper
• mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy

  2013cited by this paper
• Signal integration by mTORC1 coordinates nutrient input with biosynthetic output

  2013cited by this paper
• Systematic identification of genomic markers of drug sensitivity in cancer cells

  2012influential reference
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• mTOR signaling in growth control and disease.

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability.

  2011cited by this paper
• Predicting the functional impact of protein mutations: application to cancer genomics

  2011influential reference
• Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

  2010influential reference
• The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy.

  2009cited by this paper
• A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.

  2009cited by this paper
• Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors

  2008cited by this paper
• The role of PTEN signaling perturbations in cancer and in targeted therapy

  2008cited by this paper
• AKT/PKB signaling: navigating downstream.

  2007cited by this paper
• A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

  2007cited by this paper
• The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

  2006cited by this paper
• Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

  2005cited by this paper
• High Frequency of Mutations of the PIK3CA Gene in Human Cancers

  2004cited by this paper
• Statistical significance for genomewide studies

  2003influential reference
• Mutation of the 9q34 gene TSC1 in sporadic bladder cancer

  1999cited by this paper

• Unveiling bioactive compounds in kola nut seeds: GC-MS identification and computational analysis for anticancer potential

  2026cites this paper
• Genomic landscape of pediatric germ cell tumors reveals oncogenic mutations and copy number alterations.

  2026cites this paper
• Impact of PIK3CAH1047R Mutation on Glioblastoma Survival: Insights from a Preliminary Study

  2026cites this paper
• GPR176 enhances the epithelial-mesenchymal transition in gastric cancer cells by activating the PI3K/AKT/mTOR signaling pathway

  2026cites this paper
• AI-Guided Discovery of Oncogenic Signaling Crosstalk in Tumor Progression and Drug Resistance

  2026cites this paper
• Multiple Testing of Mix‐and‐Match Feature Sets in Multi‐Omics

  2026cites this paper
• Natural Products Targeting the PI3K/Akt/mTOR-Mediated Autophagy Pathway in Cancer Therapy: Recent Advances and Clinical Perspectives.

  2026cites this paper
• Functional Analysis of the PI3K/AKT/mTOR Pathway Inhibitor, Gedatolisib, Plus Fulvestrant with and Without Palbociclib in Breast Cancer Models

  2025cites this paper
• An Overview of Analytical Approaches to Cancer Proteogenomics.

  2025cites this paper
• Conventional and alternative approaches for targeting PIK3CA and PTEN alterations in head and neck, breast, and other cancers.

  2025cites this paper
• N-(5-(2-morpholino-4-oxo-3,4-dihydroquinazolin-8-yl)pyridin-2-yl)acylamides as novel multi-PI3K/DNA-PK/P-gp inhibitors for efficient chemosensitization and MDR alleviation.

  2025cites this paper
• Early phase development of PI3kinase inhibitors for anticancer therapies

  2025cites this paper
• Tamoxifen induces PI3K activation in uterine cancer

  2025influential citation
• Pan-cancer, multi-omic correlates of survival transcending tumor lineage across 11,019 patients reveal targets and pathways

  2025influential citation
• In defence of ferroptosis

  2025cites this paper
• Targeting on the PI3K/mTOR: a potential treatment strategy for clear cell ovarian carcinoma

  2025cites this paper
• Folate receptor-targeted pH-sensitive liposomes loaded with TGX-221 against prostate cancer by inhibiting PI3K/110β signaling

  2025cites this paper
• Farrerol inhibits proliferation and migration of colorectal cancer via the VEGF signaling pathway: evidence from network pharmacology, molecular docking, molecular dynamics simulation, and in vitro experiments

  2025cites this paper
• Comprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an AKT1 E17K–Mutated Tumor

  2025cites this paper
• Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21-P27KIP1-mTOR axis

  2025cites this paper
• Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial

  2025cites this paper
• Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment

  2025cites this paper
• Deciphering WNT Signalling Vulnerabilities in Soft Tissue Sarcoma

  2025cites this paper
• The Histomorphology to Molecular Transition: Exploring the Genomic Landscape of Poorly Differentiated Epithelial Endometrial Cancers

  2025cites this paper
• Identifying and validating PLAU as a potential prognostic biomarker for PDAC

  2025cites this paper
• Targeting PI3Kδ in cancer: a setback or the end

  2025cites this paper
• Multi-node inhibition targeting mTORC1, mTORC2 and PI3Kα potently inhibits the PI3K/AKT/mTOR pathway in endometrial and breast cancer models

  2025cites this paper
• Molecular Subtyping and Classification of PIK3CA Mutations in Metastatic Breast Cancer

  2025cites this paper
• COL6A2 in clear cell renal cell carcinoma: a multifaceted driver of tumor progression, immune evasion, and drug sensitivity

  2025cites this paper
• Interpretability-guided RNA N6-methyladenosine modification site prediction with invertible neural networks

  2025cites this paper
• Molecular Characterization of Seminoma Utilizing the AACR Project GENIE: A Retrospective Observational Study

  2025cites this paper
• Adenovirus E4ORF1 activates isoform-specific phosphatidylinositol 3-kinase signaling in human endothelial cells

  2025cites this paper
• Personalized therapy in metastatic colorectal cancer: biomarker-driven use of biologics

  2025cites this paper
• Regulation of transcriptome plasticity by mTOR signaling pathway

  2025cites this paper
• Early Detection of Wellness-to-Disease Transitions in the AI Era: Implications for Pharmacology and Toxicology.

  2025cites this paper
• Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management

  2025cites this paper
• Targeting Akt Signaling Pathway in Cancer: Molecular Mechanisms and Advances in Therapeutic Interventions.

  2025cites this paper
• Kanser Tedavisinde PI3K/AKT/mTOR Yolunun Hedeflenmesi: Yeni Nesil mTOR İnhibitörlerine Güncel Bir Değerlendirme

  2025cites this paper
• An exposure–safety analysis to support the dosage of the novel AKT inhibitor capivasertib

  2025cites this paper
• Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway

  2025cites this paper
• Biomedical engineering targeting cancer stem cells to reinforce cancer therapy

  2025cites this paper
• Blocking p85β nuclear translocation by importazole enhances Alpelisib efficacy against PIK3CA-helical-domain-mutant tumors.

  2025cites this paper
• PI3Kα-specific inhibitor BYL-719 synergizes with cisplatin in vitro in PIK3CA-mutated ovarian cancer cells

  2025cites this paper
• Translational regulation of SND1 governs endothelial homeostasis during stress

  2025cites this paper
• Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review

  2025cites this paper
• MAGE-A4 induces non–small cell lung cancer and tumor-promoting plasma cell accumulation

  2025cites this paper
• Vaginal Adenocarcinoma: A Review of a Rare Gynecologic Cancer

  2025cites this paper
• Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis

  2025cites this paper
• Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1K.

  2025cites this paper
• Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localization

  2025cites this paper
• Prevalence and clinical implications of PIK3CA aberrations across cancer types: A real-world next-generation sequencing approach.

  2025cites this paper
• Comparison of somatic variant oncogenicity classification using ClinGen/CGC/VICC guidelines and QIAGEN Clinical Insight Interpret decision support software.

  2025cites this paper
• The role and research progress of serine metabolism in tumor cells

  2025cites this paper
• Stem Cells in Cancer: From Mechanisms to Therapeutic Strategies

  2025cites this paper
• A mode of action protein based approach that characterizes the relationships among most major diseases

  2025cites this paper
• Deciphering molecular pathways in urological cancers: a gateway to precision therapeutics.

  2025cites this paper
• The multifaceted functions of SPC25 in cancer: from molecular pathways to targeted therapy

  2025cites this paper
• Integrated functional genomics-identified LYRM4 promotes fumarate accumulation and hepatocellular carcinoma progression.

  2025cites this paper
• Specific signaling pathways mediated programmed cell death in tumor microenvironment and target therapies

  2025cites this paper
• Global DNA methylation differences involving germline structural variation impact gene expression in pediatric brain tumors

  2025cites this paper
• Unlocking Diagnostic Potential: A Retrospective Analysis of GPNMB Immunohistochemistry in Nearly 1000 Surgical Pathology Specimens.

  2025cites this paper
• Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis Initiation

  2025cites this paper
• Identification of genes that promote PI3K pathway activation and prostate tumour formation

  2024cites this paper
• Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer

  2024cites this paper
• Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1

  2024cites this paper
• The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway

  2024cites this paper
• Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example

  2024cites this paper
• Tl(I) and Tl(III)-induce genotoxicity, reticulum stress and autophagy in PC12 Adh cells

  2024cites this paper
• Gentisic acid prevents colorectal cancer metastasis via blocking GPR81-mediated DEPDC5 degradation.

  2024cites this paper
• Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines

  2024cites this paper
• Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes

  2024cites this paper
• Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets

  2024cites this paper
• Growth Signaling Networks Orchestrate Cancer Metabolic Networks.

  2024cites this paper
• Bromodomain and Extraterminal Domain Protein 2 in Multiple Human Diseases

  2024cites this paper
• Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway.

  2024cites this paper
• PPIP5K2 Facilitates Proliferation and Metastasis of Non-Small Lung Cancer (NSCLC) through AKT Signaling Pathway

  2024cites this paper
• JAK3/STAT5 signaling‐triggered upregulation of PIK3CD contributes to gastric carcinoma development

  2024cites this paper
• Quantitative assessment of preanalytic variables on clinical evaluation of PI3/AKT/mTOR signaling activity in diffuse glioma.

  2024cites this paper
• Structural and Dynamic Analyses of Pathogenic Variants in PIK3R1 Reveal a Shared Mechanism Associated among Cancer, Undergrowth, and Overgrowth Syndromes

  2024cites this paper
• Sacral Bioneuromodulation: The Role of Bone Marrow Aspirate in Spinal Cord Injuries

  2024cites this paper
• A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer

  2024cites this paper
• ID2 promotes tumor progression and metastasis in thyroid cancer

  2024cites this paper
• Elucidating the Role of Pro-renin Receptors in Pancreatic Ductal Adenocarcinoma Progression: A Novel Therapeutic Target in Cancer Therapy.

  2024cites this paper
• Genetic variants in the mTOR pathway with renal cancer risk and subtypes in East Indian population

  2024cites this paper
• Galangin promotes apoptosis by upregulating the pro-apoptotic gene BAX in triple-negative breast cancer

  2024cites this paper
• Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer.

  2024cites this paper
• Phosphatidic acid as a cofactor of mTORC1 in platinum-based chemoresistance: mechanisms and therapeutic potential.

  2024cites this paper
• Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma

  2024cites this paper
• Rapid, potent, and persistent covalent chemical probes to deconvolute PI3Kα signaling

  2024cites this paper
• Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness

  2024cites this paper
• Effect of elastin on abnormal proliferation of pulmonary artery smooth muscle cells at an early stage of hypoxic exposure

  2024cites this paper
• Protein biomarkers for subtyping breast cancer and implications for future research: a 2024 update

  2024cites this paper
• OCEAN: Flexible Feature Set Aggregation for Analysis of Multi-omics Data

  2024cites this paper
• Bioinformatic analysis constructs an optimal prognostic index for survival-related variables (OPISV) based on whole-genome expression data in Glioblastoma.

  2024cites this paper
• Rare Case of a Turner Syndrome Patient with Metastatic Dysgerminoma and No Y-Chromosomal Material with Pathogenic Variants Found in KIT and MTOR

  2024cites this paper
• 27-Hydroxycholesterol inhibits trophoblast fusion during placenta development by activating PI3K/AKT/mTOR signaling pathway

  2024cites this paper
• VHL missense mutation delineate aggressive clear cell renal cell carcinoma subtype with favorable immunotherapeutic response

  2024cites this paper
• Regulatory-Associated Protein of mTOR-Mediated Signaling: A Nexus Between Tumorigenesis and Disease

  2024cites this paper
• A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies

  2024cites this paper
• Proteomics Analysis of Renal Cell Line Caki-2 with AFMID Overexpression and Potential Biomarker Discovery in Urine.

  2024cites this paper